Login to Your Account



Other News To Note


Monday, September 16, 2013
Champions Oncology Inc., of Hackensack, N.J., said it signed a new discovery and drug development partnership with Teva Pharmaceutical Industries Ltd., which will use their Tumorgraft technology platform to enhance and accelerate the clinical development of several of Teva’s oncology compounds.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription